US6197548B1
(en)
|
1990-04-02 |
2001-03-06 |
Medeva Pharma Limited |
Transformed Pichia expressing the pertactin antigen
|
US5369028A
(en)
*
|
1990-04-03 |
1994-11-29 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
|
US6440681B1
(en)
|
1990-04-03 |
2002-08-27 |
Merck & Co., Inc. |
Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
|
US5258302A
(en)
*
|
1990-07-03 |
1993-11-02 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
DNA for expression of aprotinin in methylotrophic yeast cells
|
US5612198A
(en)
*
|
1990-09-04 |
1997-03-18 |
The Salk Institute |
Production of insulin-like growth factor-1 in methylotrophic yeast cells
|
CA2090969C
(en)
*
|
1990-09-04 |
2001-08-21 |
Russell Arthur Brierley |
Production of insulin-like growth factor-1 in methylotrophic yeast cells
|
DK0574402T3
(da)
|
1990-11-26 |
1998-05-18 |
Chiron Corp |
Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
WO1992017595A1
(en)
*
|
1991-04-01 |
1992-10-15 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Genes which influence pichia proteolytic activity, and uses therefor
|
CA2125985C
(en)
*
|
1991-12-23 |
2001-04-17 |
Stewart Craig |
Stem cell inhibiting proteins
|
ATE279516T1
(de)
|
1993-03-08 |
2004-10-15 |
Merck & Co Inc |
Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
|
WO1994024284A1
(en)
|
1993-04-20 |
1994-10-27 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
|
US5912122A
(en)
*
|
1993-06-04 |
1999-06-15 |
Sibia Neurosciences, Inc. |
Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
|
US6001581A
(en)
|
1993-06-04 |
1999-12-14 |
Sibia Neurosciences, Inc. |
Cation-based bioassay using human metabotropic glutamate receptors
|
US5521297A
(en)
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
US6638905B2
(en)
*
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
GB2287941B
(en)
*
|
1993-11-08 |
1998-01-28 |
Salk Inst Biotech Ind |
Human alpha2 neuronal nicotinic acetylcholine receptor compositions and methods employing same
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
US5728676A
(en)
*
|
1994-09-08 |
1998-03-17 |
Ciba-Geigy Corporation |
Use of insulin-like growth factors I and II for inhibition of inflammatory response
|
US6485967B1
(en)
|
1995-06-07 |
2002-11-26 |
Merck & Co., Inc. |
Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
ATE505478T1
(de)
|
1997-08-27 |
2011-04-15 |
Novartis Vaccines & Diagnostic |
Molekular-mimetika von meningokokkalen b epitopen
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
DE69941567D1
(de)
|
1998-01-14 |
2009-12-03 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
CN101293920B
(zh)
|
1998-05-01 |
2012-07-18 |
诺华疫苗和诊断公司 |
脑膜炎奈瑟球菌抗原和组合物
|
EP1121437B1
(en)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
AU2367600A
(en)
|
1998-12-16 |
2000-07-03 |
Chiron Corporation |
Human cyclin-dependent kinase ((hpnqalre))
|
US6780615B1
(en)
|
1998-12-31 |
2004-08-24 |
Genway Biotech Inc. |
Production of recombinant monellin using methylotrophic yeast expression system
|
NZ530640A
(en)
|
1999-04-30 |
2006-06-30 |
Chiron S |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US7504253B2
(en)
*
|
1999-06-11 |
2009-03-17 |
The Burnham Institute For Medical Research |
Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
JP2003527833A
(ja)
|
1999-10-14 |
2003-09-24 |
クロンテック・ラボラトリーズ・インコーポレーテッド |
花虫類に由来する発色団/蛍光体、およびそれらの使用法
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
EP1985701B1
(en)
|
2000-01-10 |
2012-05-30 |
Novartis Vaccines and Diagnostics, Inc. |
Genes differentially expressed in breast cancer
|
RU2279889C2
(ru)
|
2000-01-17 |
2006-07-20 |
Чирон С.Р.Л. |
ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
EP1297172B1
(en)
*
|
2000-06-28 |
2005-11-09 |
Glycofi, Inc. |
Methods for producing modified glycoproteins
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
AU7765801A
(en)
|
2000-06-30 |
2002-01-08 |
Flanders Interuniversity Inst |
Protein glycosylation modification in pichia pastoris
|
US7009045B2
(en)
*
|
2000-07-14 |
2006-03-07 |
Archer-Daniels-Midland Company |
Transformation systems for flavinogenic yeast
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
WO2002059337A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Georgetown University School Of Medicine |
Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
AU2002305151A1
(en)
*
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
*
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
AU2002303262A1
(en)
*
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene shinc-1 and diagnostic and therapeutic uses thereof
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
CN1585822A
(zh)
|
2001-11-16 |
2005-02-23 |
拜奥根Idec公司 |
抗体的多顺反子表达
|
JP4413617B2
(ja)
|
2001-12-12 |
2010-02-10 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
Chlamydiatrachomatisに対する免疫化
|
JP4700281B2
(ja)
*
|
2001-12-19 |
2011-06-15 |
ザ・ユニバーシティ・オブ・シカゴ |
急速に成熟する蛍光タンパク質およびその使用法
|
US7244565B2
(en)
*
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US7138512B2
(en)
*
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
CA2482485A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Merck & Co., Inc. |
Matrix analysis of gene expression in cells (magec)
|
US20030228317A1
(en)
*
|
2002-05-22 |
2003-12-11 |
Prafulla Gokhale |
Gene BRCC-1 and diagnostic and therapeutic uses thereof
|
AU2003243316A1
(en)
*
|
2002-05-24 |
2003-12-12 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
EP1554302A4
(en)
*
|
2002-05-24 |
2006-05-03 |
Restoragen Inc |
DNA RECOMBINATION METHODS AND PRODUCTS FOR HIGH-YIELD PRODUCTION OF POLYPEPTIDES
|
AU2003239865A1
(en)
*
|
2002-05-24 |
2003-12-12 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
EP1551435A4
(en)
*
|
2002-05-24 |
2007-08-08 |
Restoragen Inc |
PROCESS FOR THE ENZYMATIC GENERATION OF GLP-1 (7-36) AMIDEPEPIDES
|
EP1521767B1
(en)
|
2002-05-24 |
2009-12-16 |
Restoragen Inc. |
Methods and constructs for high yield expression of clostripain
|
IL165717A0
(en)
|
2002-06-26 |
2006-01-15 |
Flanders Interuniversity Inst |
A strain of methylotrophic yeast for producing proteins
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
DE60335602D1
(de)
*
|
2002-12-18 |
2011-02-17 |
Roche Diagnostics Gmbh |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
DE60319333D1
(de)
*
|
2002-12-20 |
2008-04-10 |
Roche Diagnostics Gmbh |
Hitzelabile Desoxyribonuklease I-Varianten
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
EP1460425A1
(en)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Deglycosylated enzymes for conjugates
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
WO2005014825A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Arriva Pharmaceuticals, Inc. |
Methods of protein production in yeast
|
DK1673457T3
(da)
*
|
2003-08-25 |
2011-09-05 |
Funzyme Biotechnologies Sa |
Nye svampeproteiner og nukleinsyrer, der koder for disse
|
US20070274988A1
(en)
*
|
2003-10-10 |
2007-11-29 |
Five Prime Therapeautics, Inc. |
Kiaa0779, Splice Variants Thereof, and Methods of Their Use
|
DK1684719T3
(da)
*
|
2003-11-14 |
2012-01-30 |
Baxter Int |
Alfa-1-antitrypsin-sammensætninger og behandlingsfremgangsmåder, der anvender sådanne sammensætninger
|
SI1704234T1
(sl)
*
|
2003-11-21 |
2012-08-31 |
Nps Pharma Inc |
Proizvodnja glukagonu podobnih peptidov 2 in analogov
|
JP4411192B2
(ja)
*
|
2003-12-05 |
2010-02-10 |
エフ.ホフマン−ラ ロシュ アーゲー |
組換えで発現されるカルボキシペプチダーゼbおよびその精製
|
CA2553040A1
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
US7250298B2
(en)
*
|
2004-04-07 |
2007-07-31 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
CN102603895B
(zh)
*
|
2004-06-18 |
2016-09-28 |
Ambrx公司 |
新颖抗原结合多肽和其用途
|
BRPI0512396A
(pt)
*
|
2004-07-21 |
2008-03-11 |
Ambrx Inc |
polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente
|
US20070105768A1
(en)
*
|
2004-11-10 |
2007-05-10 |
Rajiv Nayar |
Dry recombinant human alpha 1-antitrypsin formulation
|
WO2006073846A2
(en)
|
2004-12-22 |
2006-07-13 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
KR101252835B1
(ko)
|
2004-12-22 |
2013-04-10 |
암브룩스, 인코포레이티드 |
아미노아실-tRNA 합성효소의 조성물 및 그것의 용도
|
NZ555386A
(en)
|
2004-12-22 |
2011-01-28 |
Ambrx Inc |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
KR20070090023A
(ko)
|
2004-12-22 |
2007-09-04 |
암브룩스, 인코포레이티드 |
변형 인간 성장 호르몬
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
KR101447897B1
(ko)
|
2005-03-21 |
2014-10-07 |
비로베이, 인코포레이티드 |
시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물
|
EP3214095B1
(en)
|
2005-05-12 |
2019-12-11 |
ZymoGenetics, Inc. |
Compositions and methods for modulating immune responses
|
CN101247821B
(zh)
*
|
2005-06-03 |
2013-01-23 |
Ambrx公司 |
经改良人类干扰素分子和其用途
|
KR101285904B1
(ko)
*
|
2005-08-18 |
2013-07-15 |
암브룩스, 인코포레이티드 |
tRNA 조성물 및 이의 용도
|
AU2006291780B2
(en)
*
|
2005-09-14 |
2011-12-08 |
F. Hoffmann-La Roche Ag |
Cleavage of precursors of insulins by a variant of trypsin
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
PL1954710T3
(pl)
*
|
2005-11-08 |
2011-09-30 |
Ambrx Inc |
Przyspieszacze do modyfikacji aminokwasów niewystępujących w przyrodzie i polipeptydów zbudowanych z aminokwasów nie występujących w przyrodzie
|
KR20080079643A
(ko)
*
|
2005-11-16 |
2008-09-01 |
암브룩스, 인코포레이티드 |
비-천연 아미노산을 포함하는 방법 및 조성물
|
US20080317670A1
(en)
*
|
2005-12-14 |
2008-12-25 |
Ambrx, Inc. |
Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
EP2069396B1
(en)
*
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
PT2064333E
(pt)
*
|
2006-09-08 |
2014-06-09 |
Ambrx Inc |
Supressor híbrido arnt para células de vertebrados
|
KR20090051227A
(ko)
*
|
2006-09-08 |
2009-05-21 |
암브룩스, 인코포레이티드 |
척추동물 세포를 위한 하이브리드 서프레서 tRNA
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
US8288110B2
(en)
*
|
2006-12-04 |
2012-10-16 |
Perkinelmer Health Sciences, Inc. |
Biomarkers for detecting cancer
|
CN104163864B
(zh)
*
|
2007-03-30 |
2017-08-01 |
Ambrx公司 |
经修饰fgf‑21多肽和其用途
|
US8026083B2
(en)
|
2007-04-03 |
2011-09-27 |
Oxyrane Uk Limited |
Yarrowia lipolytica and Pichia pastoris HAC1 nucleic acids
|
AU2008247815B2
(en)
*
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
JP4789012B2
(ja)
*
|
2007-05-07 |
2011-10-05 |
株式会社ナガエ |
物干装置
|
DK3078743T3
(da)
|
2007-09-28 |
2020-08-10 |
Portola Pharm Inc |
Antidoter til faktor xa-inhibitorer og fremgangsmåder til anvendelse af disse
|
AU2008308509B2
(en)
|
2007-10-04 |
2014-10-23 |
Zymogenetics, Inc. |
B7 family member zB7H6 and related compositions and methods
|
WO2009059305A2
(en)
*
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
MX338336B
(es)
*
|
2007-11-20 |
2016-04-07 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
WO2009073511A2
(en)
*
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
CN101939443B
(zh)
|
2008-02-08 |
2014-01-29 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
FR2927254B1
(fr)
*
|
2008-02-12 |
2010-03-26 |
Lesaffre & Cie |
Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
|
SG188846A1
(en)
*
|
2008-03-03 |
2013-04-30 |
Abbott Lab |
Methods for transforming yeast
|
CA3138282A1
(en)
|
2008-06-02 |
2009-12-10 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides
|
PT2318029T
(pt)
*
|
2008-07-23 |
2018-01-10 |
Ambrx Inc |
Polipéptidos de g-csf bovino modificados e suas utilizações
|
ES2660000T3
(es)
|
2008-09-26 |
2018-03-20 |
Ambrx, Inc. |
Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
|
EP2342223B1
(en)
|
2008-09-26 |
2017-04-26 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
EP3604510A1
(en)
|
2009-03-30 |
2020-02-05 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
PT2453910T
(pt)
|
2009-07-15 |
2016-12-07 |
Portola Pharm Inc |
Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
|
WO2011039634A2
(en)
|
2009-09-29 |
2011-04-07 |
Universiteit Gent |
Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
|
KR20130055555A
(ko)
|
2009-11-19 |
2013-05-28 |
옥시레인 유케이 리미티드 |
효모 스트레인 생성용 포유류 유사 복합 n-글리칸들
|
US20120283171A1
(en)
|
2009-12-21 |
2012-11-08 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
CA2784944A1
(en)
|
2009-12-21 |
2011-06-30 |
Centre Hospitalier Universitaire Vaudois |
Synergic action of a prolyl protease and tripeptidyl proteases
|
SG181769A1
(en)
|
2009-12-21 |
2012-07-30 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
FR2954349A1
(fr)
|
2009-12-22 |
2011-06-24 |
Agronomique Inst Nat Rech |
Sulfatase modifiant selectivement les glycosaminoglycanes
|
US8617856B2
(en)
*
|
2010-01-07 |
2013-12-31 |
Wisconsin Alumni Research Foundation |
Fatty acid-producing hosts
|
PL2605789T3
(pl)
|
2010-08-17 |
2019-11-29 |
Ambrx Inc |
Zmodyfikowane polipeptydy relaksyny i ich zastosowania
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
CA2812870C
(en)
|
2010-09-29 |
2020-06-09 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
CA2812872C
(en)
|
2010-09-29 |
2021-08-03 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated n-glycans
|
EP2710114B1
(en)
|
2011-05-20 |
2021-11-03 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
|
JP6138788B2
(ja)
|
2011-08-19 |
2017-05-31 |
アルダーバイオ・ホールディングズ・エルエルシー |
形質転換した微生物、例えばピキア・パストリス中で抗体などのマルチサブユニットタンパク質を高濃度かつ高純度で生産するための多コピー法
|
EP2798074A1
(en)
|
2011-12-30 |
2014-11-05 |
Oxyrane UK Limited |
Methods and materials for reducing degradation of recombinant proteins
|
US20130230901A1
(en)
|
2012-02-14 |
2013-09-05 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|
CN104379162B
(zh)
|
2012-03-15 |
2017-03-15 |
奥克西雷恩英国有限公司 |
用于治疗蓬佩氏病的方法和材料
|
US20140073022A1
(en)
|
2012-09-10 |
2014-03-13 |
Wisconsin Alumni Research Foundation |
Production of polyhydroxyalkanoates with a defined composition from an unrelated carbon source
|
CN105377288B
(zh)
|
2012-11-05 |
2019-11-15 |
达纳-法伯癌症研究所股份有限公司 |
Xbp1、cd138和cs1肽的组合物制备药物的用途
|
US20190040368A1
(en)
|
2013-03-05 |
2019-02-07 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
JP6472786B2
(ja)
|
2013-03-15 |
2019-02-20 |
アルダー・バイオファーマシューティカルズ・インコーポレーテッド |
抗体の精製及び純度のモニタリング
|
SG11201506034TA
(en)
|
2013-03-15 |
2015-09-29 |
Alder Biopharmaceuticals Inc |
Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
|
CN105143243B
(zh)
|
2013-03-21 |
2020-03-13 |
国家科学和工业研究组织 |
三螺旋蛋白的纯化
|
TWI738631B
(zh)
|
2013-09-09 |
2021-09-11 |
德商贏創運營有限公司 |
經修飾之細菌類膠原蛋白蛋白質
|
US9708630B1
(en)
|
2013-10-08 |
2017-07-18 |
Wisconsin Alumni Research Foundation |
Cells and methods for producing fatty alcohols
|
KR20240024362A
(ko)
|
2014-10-24 |
2024-02-23 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
WO2016120764A1
(en)
|
2015-01-26 |
2016-08-04 |
Centre Hospitalier Universitaire Vaudois (Chuv) |
Aspergillus oryzae prolyl endopeptidases and use thereof in degradation of polypeptides
|
US9920102B2
(en)
|
2015-05-15 |
2018-03-20 |
Albert Einstein College Of Medicine, Inc. |
Fusion tags for protein expression
|
US10301653B2
(en)
|
2015-07-06 |
2019-05-28 |
Wisconsin Alumni Research Foundation |
Microorganisms that co-consume glucose with non-glucose carbohydrates and methods of use
|
US10287338B2
(en)
|
2015-07-10 |
2019-05-14 |
Miran NERSISSIAN |
Factor VIII protein compositions and methods of treating of hemophilia A
|
CN108368505B
(zh)
|
2015-10-09 |
2023-02-21 |
建新公司 |
改善的flare(流式细胞术减弱报道蛋白表达)技术用于快速批量分选
|
EP3393501B1
(en)
|
2015-12-24 |
2023-06-07 |
Oxyrane UK Limited |
Human alpha-n-acetylgalactosaminidase polypeptide
|
US10421951B2
(en)
|
2016-06-22 |
2019-09-24 |
Wisconsin Alumni Research Foundation |
Gene construct encoding mutant thioesterase, mutant thioesterase encoded thereby, transformed host cell containing the gene construct, and method of using them to produce medium-chain fatty acids
|
CA3039598A1
(en)
|
2016-10-07 |
2018-04-12 |
Genzyme Corporation |
Early post-transfection isolation of cells (epic) for biologics production
|
SG10201912034UA
(en)
|
2017-02-08 |
2020-02-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
AU2018326805B2
(en)
|
2017-09-01 |
2023-11-30 |
Dana-Farber Cancer Institute, Inc. |
Immunogenic peptides specific to BCMA and TACI antigens for treatment of cancer
|
US11603412B2
(en)
|
2017-10-25 |
2023-03-14 |
The Regents Of The University Of California |
Antibodies against CDCP1 for the treatment and detection of cancer
|
EP3505181B1
(en)
|
2017-12-28 |
2021-07-07 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Preparation of enzyme replacement therapy for mucopolysaccharidosis iiid
|
CA3131138A1
(en)
|
2019-03-06 |
2020-09-10 |
Dana-Farber Cancer Institute, Inc. |
T cell receptors specific to b-cell maturation antigen for treatment of cancer
|
US20220251534A1
(en)
|
2019-08-08 |
2022-08-11 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for preparing factor xa and derivatives
|
US20230183759A1
(en)
|
2020-05-20 |
2023-06-15 |
Wisconsin Alumni Research Foundation |
Cells and methods for producing methyl ketones
|
US20240218383A1
(en)
|
2021-05-12 |
2024-07-04 |
Circular Industries Holding Pte Ltd. |
Recombinant yeasts for producing acetone and/or isopropanol from fatty acid feedstocks
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
WO2024032891A1
(en)
|
2022-08-11 |
2024-02-15 |
Vib Vzw |
Glyco-engineered yeast for therapeutic protein production
|